A Prospective Natural History Study of Post Acute Sequalae of COVID-19 Using Digital Wearables: Study Protocol

Overview

Journal Res Sq

Date 2023 Dec 18

PMID 38105936

Authors

Sherine El-Toukhy

Phillip Hegeman

Gabrielle Zuckerman

Roy Das Anirban

Nia Moses

James F Troendle

Tiffany M Powell-Wiley

Affiliations

Soon will be listed here.

Abstract

Background: Post-acute sequelae of COVID-19 (PASC) is characterized by having 1 + persistent, recurrent, or emergent symptoms post the infection's acute phase. The duration and symptom manifestation of PASC remain understudied in nonhospitalized patients. Literature on PASC is primarily based on data from hospitalized patients where clinical indicators such as respiratory rate, heart rate, and oxygen saturation have been predictive of disease trajectories. Digital wearables allow for a continuous collection of such physiological parameters. This protocol outlines the design, aim, and procedures of a natural history study of PASC using digital wearables.

Methods: This is a single-arm, prospective, natural history study of a cohort of 550 patients, ages 18 to 65 years old, males or females who own a smartphone and/or a tablet that meets pre-determined Bluetooth version and operating system requirements, speak English, and provide documentation of a positive COVID-19 test issued by a healthcare professional or organization within 5 days before enrollment. The study aims to identify wearables collected physiological parameters that are associated with PASC in patients with a positive diagnosis. The primary endpoint is long COVID-19, defined as ≥ 1 symptom at 3 weeks beyond first symptom onset or positive diagnosis, whichever comes first. The secondary endpoint is chronic COVID-19, defined as ≥ 1 symptom at 12 weeks beyond first symptom onset or positive diagnosis. We hypothesize that physiological parameters collected via wearables are associated with self-reported PASC. Participants must be willing and able to consent to participate in the study and adhere to study procedures for six months.

Discussion: This is a fully decentralized study investigating PASC using wearable devices to collect physiological parameters and patient-reported outcomes. Given evidence on key demographics and risk profiles associated with PASC, the study will shed light on the duration and symptom manifestation of PASC in nonhospitalized patient subgroups and is an exemplar of use of wearables as population-level monitoring health tools for communicable diseases.

Trial Registration: ClinicalTrials.gov NCT04927442.

References

Golinelli D, Boetto E, Carullo G, Nuzzolese A, Landini M, Fantini M . Adoption of Digital Technologies in Health Care During the COVID-19 Pandemic: Systematic Review of Early Scientific Literature. J Med Internet Res. 2020; 22(11):e22280. PMC: 7652596. DOI: 10.2196/22280. View

Ray Dorsey E, Kluger B, Lipset C . The New Normal in Clinical Trials: Decentralized Studies. Ann Neurol. 2020; 88(5):863-866. DOI: 10.1002/ana.25892. View

Stuckless S, Parfrey P . Bias in Clinical Research. Methods Mol Biol. 2021; 2249:17-34. DOI: 10.1007/978-1-0716-1138-8_2. View

Choi S, Victorson D, Yount S, Anton S, Cella D . Development of a conceptual framework and calibrated item banks to measure patient-reported dyspnea severity and related functional limitations. Value Health. 2011; 14(2):291-306. DOI: 10.1016/j.jval.2010.06.001. View

Davis H, Assaf G, McCorkell L, Wei H, Low R, Reem Y . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021; 38:101019. PMC: 8280690. DOI: 10.1016/j.eclinm.2021.101019. View

Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

Guzman-Esquivel J, Mendoza-Hernandez M, Guzman-Solorzano H, Sarmiento-Hernandez K, Rodriguez-Sanchez I, Martinez-Fierro M . Clinical Characteristics in the Acute Phase of COVID-19 That Predict Long COVID: Tachycardia, Myalgias, Severity, and Use of Antibiotics as Main Risk Factors, While Education and Blood Group B Are Protective. Healthcare (Basel). 2023; 11(2). PMC: 9858709. DOI: 10.3390/healthcare11020197. View

Bhavnani S, Narula J, Sengupta P . Mobile technology and the digitization of healthcare. Eur Heart J. 2016; 37(18):1428-38. PMC: 4914890. DOI: 10.1093/eurheartj/ehv770. View

Fiordelli M, Diviani N, Schulz P . Mapping mHealth research: a decade of evolution. J Med Internet Res. 2013; 15(5):e95. PMC: 3668610. DOI: 10.2196/jmir.2430. View

10.

Shapiro A, Marinsek N, Clay I, Bradshaw B, Ramirez E, Min J . Characterizing COVID-19 and Influenza Illnesses in the Real World via Person-Generated Health Data. Patterns (N Y). 2021; 2(1):100188. PMC: 7815963. DOI: 10.1016/j.patter.2020.100188. View

11.

Radin J, Wineinger N, Topol E, Steinhubl S . Harnessing wearable device data to improve state-level real-time surveillance of influenza-like illness in the USA: a population-based study. Lancet Digit Health. 2020; 2(2):e85-e93. PMC: 8048388. DOI: 10.1016/S2589-7500(19)30222-5. View

12.

Price-Haywood E, Burton J, Fort D, Seoane L . Hospitalization and Mortality among Black Patients and White Patients with Covid-19. N Engl J Med. 2020; 382(26):2534-2543. PMC: 7269015. DOI: 10.1056/NEJMsa2011686. View

13.

Tenforde M, Rose E, Lindsell C, Shapiro N, Files D, Gibbs K . Characteristics of Adult Outpatients and Inpatients with COVID-19 - 11 Academic Medical Centers, United States, March-May 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(26):841-846. PMC: 7332092. DOI: 10.15585/mmwr.mm6926e3. View

14.

Cutler D . The Costs of Long COVID. JAMA Health Forum. 2022; 3(5):e221809. DOI: 10.1001/jamahealthforum.2022.1809. View

15.

Greenhalgh T, Knight M, ACourt C, Buxton M, Husain L . Management of post-acute covid-19 in primary care. BMJ. 2020; 370:m3026. DOI: 10.1136/bmj.m3026. View

16.

Mahase E . Covid-19: What do we know about "long covid"?. BMJ. 2020; 370:m2815. DOI: 10.1136/bmj.m2815. View

17.

Puntmann V, Carerj M, Wieters I, Fahim M, Arendt C, Hoffmann J . Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(11):1265-1273. PMC: 7385689. DOI: 10.1001/jamacardio.2020.3557. View

18.

. Post-COVID-19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res. 2020; 32(8):1613-1620. PMC: 7287410. DOI: 10.1007/s40520-020-01616-x. View

19.

Lam M, Wing Y, Yu M, Leung C, Ma R, Kong A . Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009; 169(22):2142-7. DOI: 10.1001/archinternmed.2009.384. View

20.

Brannock M, Chew R, Preiss A, Hadley E, Redfield S, McMurry J . Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program. Nat Commun. 2023; 14(1):2914. PMC: 10201472. DOI: 10.1038/s41467-023-38388-7. View